| Changes to trial information |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Trial Information |
Trial phase |
22/06/2026 |
the phase of the trial is not applicable as no drugs or vaccine used , it is a surgical intervention. |
Phase-1 |
Not Applicable |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Trial Information |
Purpose of the trial |
22/06/2026 |
The study includes surgical intervention. |
Treatment: Other |
Treatment: Surgery |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Trial Information |
Anticipated date of last follow up |
05/08/2026 |
We increased the number of patients from 95 to 118 , as a minimum of 118 patients per group (236 total) was required to detect this difference between the two groups based on the incidence of postoperative urinary tract infection (UTI) reported by Kasahara et al., in which the cold saline group had a UTI incidence of 7.4% compared to 19.7% in the room-temperature group. Assuming a two-sided alpha of 0.05 and a power of 80% |
31 Jul 2026 |
25 Aug 2026 |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Trial Information |
Completion date |
19/08/2026 |
The Study is now complete. |
|
11 Aug 2026 |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Trial Information |
Target no of participants |
05/08/2026 |
We increased the number of patients from 95 to 118 , as a minimum of 118 patients per group (236 total) was required to detect this difference between the two groups based on the incidence of postoperative urinary tract infection (UTI) reported by Kasahara et al., in which the cold saline group had a UTI incidence of 7.4% compared to 19.7% in the room-temperature group. Assuming a two-sided alpha of 0.05 and a power of 80% |
238 |
260 |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Trial Information |
Final no of participants |
05/08/2026 |
We increased the number of patients from 95 to 118 , as a minimum of 118 patients per group (236 total) was required to detect this difference between the two groups based on the incidence of postoperative urinary tract infection (UTI) reported by Kasahara et al., in which the cold saline group had a UTI incidence of 7.4% compared to 19.7% in the room-temperature group. Assuming a two-sided alpha of 0.05 and a power of 80% |
190 |
236 |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Trial Information |
Recruitment status |
05/08/2026 |
We increased the number of patients from 95 to 118 , as a minimum of 118 patients per group (236 total) was required to detect this difference between the two groups based on the incidence of postoperative urinary tract infection (UTI) reported by Kasahara et al., in which the cold saline group had a UTI incidence of 7.4% compared to 19.7% in the room-temperature group. Assuming a two-sided alpha of 0.05 and a power of 80% |
Closed to recruitment,follow-up continuing |
Recruiting |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Trial Information |
Recruitment status |
05/08/2026 |
We increased the number of patients from 95 to 118 , as a minimum of 118 patients per group (236 total) was required to detect this difference between the two groups based on the incidence of postoperative urinary tract infection (UTI) reported by Kasahara et al., in which the cold saline group had a UTI incidence of 7.4% compared to 19.7% in the room-temperature group. Assuming a two-sided alpha of 0.05 and a power of 80% |
Recruiting |
Closed to recruitment,follow-up continuing |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Trial Information |
Recruitment status |
19/08/2026 |
The Study is now complete. |
Closed to recruitment,follow-up continuing |
Completed |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Trial Information |
Disease(s) |
22/06/2026 |
the trial related to kidney diseases ( renal stones ) |
Urological and Genital Diseases |
Urological and Genital Diseases, Kidney Disease |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Intervention |
Intervention List |
05/08/2026 |
We increased the number of patients from 95 to 118 , as a minimum of 118 patients per group (236 total) was required to detect this difference between the two groups based on the incidence of postoperative urinary tract infection (UTI) reported by Kasahara et al., in which the cold saline group had a UTI incidence of 7.4% compared to 19.7% in the room-temperature group. Assuming a two-sided alpha of 0.05 and a power of 80% |
Control Group, Retrograde intrarenal surgery using saline at room temperature irrigation, Continuous manually adjusted irrigation at rate of 20 ml/ minute during the procedure as needed for visualization, Intraoperative : after insertion of Ureteral access sheath for identification of the stone till the end of stone fragmentation . average operative time is 60-90 minutes, Patients in this group undergo retrograde intrarenal surgery (RIRS) using standard commercial normal saline fluid maintained and delivered at stable room temperature (approximately 20–25°C) for endourological irrigation., 95, Active-Treatment of Control Group |
Control Group, Retrograde intrarenal surgery using saline at room temperature irrigation, Continuous manually adjusted irrigation at rate of 20 ml/ minute during the procedure as needed for visualization, Intraoperative : after insertion of Ureteral access sheath for identification of the stone till the end of stone fragmentation . average operative time is 60-90 minutes, Patients in this group undergo retrograde intrarenal surgery (RIRS) using standard commercial normal saline fluid maintained and delivered at stable room temperature (approximately 20–25°C) for endourological irrigation., 118, Active-Treatment of Control Group |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Intervention |
Intervention List |
05/08/2026 |
We increased the number of patients from 95 to 118 , as a minimum of 118 patients per group (236 total) was required to detect this difference between the two groups based on the incidence of postoperative urinary tract infection (UTI) reported by Kasahara et al., in which the cold saline group had a UTI incidence of 7.4% compared to 19.7% in the room-temperature group. Assuming a two-sided alpha of 0.05 and a power of 80% |
Experimental Group, Retrograde intrarenal surgery using cold saline irrigation., Continuous manually adjusted irrigation at rate of 20 ml/ minute during the procedure as needed for visualization, Intraoperative : after insertion of Ureteral access sheath for identification of the stone till the end of stone fragmentation . average operative time is 60-90 minutes, Patients in this group undergo retrograde intrarenal surgery (RIRS) using cold saline irrigation at approximately 3–5°C for endourological irrigation with low power laser settings ( 12- 18 W ) in dusting mode
, 95, |
Experimental Group, Retrograde intrarenal surgery using cold saline irrigation., Continuous manually adjusted irrigation at rate of 20 ml/ minute during the procedure as needed for visualization, Intraoperative : after insertion of Ureteral access sheath for identification of the stone till the end of stone fragmentation . average operative time is 60-90 minutes, Patients in this group undergo retrograde intrarenal surgery (RIRS) using cold saline irrigation at approximately 3–5°C for endourological irrigation with low power laser settings ( 12- 18 W ) in dusting mode
, 118, |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Outcome |
OutCome List |
02/07/2026 |
wrong data entry |
Primary Outcome, The clarity of the endoscopic surgical field according to visualization scale , During the percedure |
Primary Outcome, The clarity of the endoscopic surgical field according to visualization scale , During the procedure |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Ethics |
Ethics List |
20/08/2026 |
the ethics approval letter from the ethics committee |
TRUE, Research Ethics Committee Banha Faculty of Medicine, El-Shaheed Farid Nada, Qism Banha, Banha, 6470201, Egypt, , 28 Sep 2025, +201158652937, ethical.committee@fmed.bu.edu, 41515_38815_4737.pdf |
TRUE, Research Ethics Committee Banha Faculty of Medicine, El-Shaheed Farid Nada, Qism Banha, Banha, 6470201, Egypt, , 28 Sep 2025, +201158652937, ethical.committee@fmed.bu.edu, 41515_38815_4737.pdf |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Funding Source |
FundingSources List |
22/06/2026 |
Wrong data entry. |
|
Benha University Hospital, El-Shaheed Farid Nada, Qism Banha, Banha, 6470201, Egypt, University, |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Contact People |
Contacs List |
19/08/2026 |
Wrong data. |
Public Enquiries, Mahmoud Abdel hameed, Elshamy, Dr., dr.mahmoud.elshamy.5797@gmail.com, dr.ma7moud.elshamy@gmail.com, +201028495275, Arramla, Benha , 13722, Egypt, Urology Resistant |
Public Enquiries, Mahmoud Abdelhamid, Elshamy, Dr., dr.mahmoud.elshamy.5797@gmail.com, dr.ma7moud.elshamy@gmail.com, +201028495275, Arramla, Benha , 13722, Egypt, Urology Resistant |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Contact People |
Contacs List |
20/08/2026 |
Wrong data |
Scientific Enquiries, Mohamed Abdel rahman, Alhefnawy, Prof., mohamed.alhefnawy@fmed.bu.edu.eg, dr.mohamedalhefnawy@gmail.com, +201003481084, Zefta, Gharbia Governorate, Gharbia Governorate, 6660180, Egypt, Professor at urology department Banha University |
Scientific Enquiries, Mohamed Abdelrahman, Alhefnawy, Prof., mohamed.alhefnawy@fmed.bu.edu.eg, dr.mohamedalhefnawy@gmail.com, +201003481084, Zefta, Gharbia Governorate, Gharbia Governorate, 6660180, Egypt, Professor at urology department Banha University |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Contact People |
Contacs List |
22/06/2026 |
Wrong Contacts entery |
|
Principal Investigator, Mahmoud Abdel hameed , Elshamy, Dr., dr.mahmoud.elshamy.5797@gmail.com, mahmoud150378@fmed.bu.edu.eg, +201028495275, Arramla, Banha, 13722, Egypt, Urology Resistant at National Institute of Urology and Nephrology |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Contact People |
Contacs List |
19/08/2026 |
Wrong Contact entry |
Principal Investigator, Mahmoud Abdel hameed , Elshamy, Dr., dr.mahmoud.elshamy.5797@gmail.com, mahmoud150378@fmed.bu.edu.eg, +201028495275, Arramla, Banha, 13722, Egypt, Urology Resistant at National Institute of Urology and Nephrology |
Principal Investigator, Mahmoud Abdelhamid, Elshamy, Dr., dr.mahmoud.elshamy.5797@gmail.com, mahmoud150378@fmed.bu.edu.eg, +201028495275, Arramla, Banha, 13722, Egypt, Urology Resistant at National Institute of Urology and Nephrology |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Reporting |
IPD description |
22/06/2026 |
Upon final review of the institutional review board (IRB) approved informed consent forms, it was determined that participant consent did not include authorization to share de-identified individual participant data with external researchers |
De-identified individual participant data that underlie the results reported in the final article (including text, tables, and figures) will be made available to researchers who provide a methodologically sound proposal. |
Individual participant data will not be shared. Informed consent obtained from participants did not include provisions for the sharing of de-identified individual participant data with external researchers |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Reporting |
IPD-Sharing time frame |
22/06/2026 |
Upon final review of the institutional review board (IRB) approved informed consent forms, it was determined that participant consent did not include authorization to share de-identified individual participant data with external researchers |
Data will become available beginning 6 months after publication of the main study results and will remain available for up to 3 years |
Not applicable as there are no plans to share individual participant data. |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Reporting |
Key access criteria |
22/06/2026 |
Upon final review of the institutional review board (IRB) approved informed consent forms, it was determined that participant consent did not include authorization to share de-identified individual participant data with external researchers |
Data requests should be directed to the corresponding author. To gain access, requestors will need to sign a data access agreement and provide an approved research protocol. |
Not applicable as there are no plans to share individual participant data. |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Reporting |
Study protocol document |
22/06/2026 |
Upon final review of the institutional review board (IRB) approved informed consent forms, it was determined that participant consent did not include authorization to share de-identified individual participant data with external researchers |
Study Protocol, Informed Consent Form |
Study Protocol |